FOXP3 and colitis: Furthermore, we have recently found that endoscopic administration of eASCs in the colon submucosa of TNBS-colitic rats attenuated the severity of colitis and reduced inflammation, which was associated to increased expression of Foxp3 and IL−10 mRNA in mLNs of eASC-treated rats [47].